Skip to main content

Displaying results 1 - 3 of 3
  • Content Type: Abstract

    Adverse drug events (ADEs) are a significant source of morbidity and mortality. The majority of post-marketing surveillance for ADEs is passive. Information regarding ADEs is reported to the medical community in peer-reviewed journals. However, in… read more
    … reports, there is no corresponding abstract to view. Due to the lack of an abstract, detection depends almost … reports, there is no corresponding abstract to view. Due to the lack of an abstract, detection depends almost … permitting all non-commercial use, distribution, and reproduction in …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a major cause of morbidity and mortality. However, post-marketing surveillance systems are passive and reporting is generally not mandated. Thus, many ADEs go unreported, and it is difficult to estimate and/or… read more
    … then obtained search volume data from Google Insight for all possible pairs of drugs and ADEs. Using a set of … search volume for the majority of the drugs. This may be due to prior elevated interest as the result of previous … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …
  • Content Type: Abstract

    Disease screening facilitates the reduction of disease prevalence in two ways: (1) by preventing transmission and (2) allowing for treatment of infected individuals. Hospitals choosing an optimal screening level must weigh the benefits of decreased… read more
    … permitting all non-commercial use, distribution, and reproduction in … ehtj11115 ehtj11120 ehtj11024 ehtj11060 ehtj11110 26-50 ehtj11034 ehtj11198 ehtj11174 ehtj11048 ehtj11154 …